NCT06540963
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06540963
Title Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Giselle Sholler
Indications
Therapies
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Arkansas Children's Hospital RECRUITING Little Rock Arkansas 72202 United States Details
Randall Children's Hospital RECRUITING Portland Oregon 97227 United States Details
Penn State Milton S. Hershey Medical Center and Children's Hospital RECRUITING Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field